Colin Mann
Impact in
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Viral gastroenteritis research and epidemiology
- Virology top 10%
- HIV Research and Treatment
Papers in
- Virology 4
- HIV Research and Treatment 4
-
- SARS-CoV-2 and COVID-19 Research 4
- Viral Infections and Vectors 3
- COVID-19 Clinical Research Studies 2
- Viral Infections and Outbreaks Research 2
- Co-authors
- Galit AlterErica Ollmann SaphireJiang ZhuStephanie FischingerXiaohe LinLinling HeFlorian KrammerFatima Amanat
- Journals
- Science Translational Medicine (2 papers)mBio (2 papers)Cell Reports (2 papers)Science Advances (2 papers)Nature Communications (1 paper)
- Partner nations
- United StatesCanadaChina
In The Last Decade
Colin Mann
18 papers receiving 438 citations
Peers
Comparison fields: 5 of 63
- Infectious Diseases 258
- Virology 60
- Immunology 117
- Radiology, Nuclear Medicine and Imaging 101
- Hepatology 32
Countries citing papers authored by Colin Mann
This map shows the geographic impact of Colin Mann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Colin Mann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Colin Mann more than expected).
Fields of papers citing papers by Colin Mann
This network shows the impact of papers produced by Colin Mann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Colin Mann. The network helps show where Colin Mann may publish in the future.
Co-authors
The 25 scholars most cited alongside Colin Mann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 13 | |
| 3 | 2023 | 9 | |
| 4 | 2023 | 3 | |
| 5 | 2022 | 76 | |
| 6 | Cost-effectiveness of broadly neutralizing antibodies for HIV prophylaxis for all infants born in high-burden settings | 2022 | 1 |
| 7 | 2022 | 59 | |
| 8 | 2022 | 21 | |
| 9 | 2021 | 86 | |
| 10 | 2021 | 3 | |
| 11 | 2020 | 1 | |
| 12 | 2020 | 45 | |
| 13 | 2018 | 60 | |
| 14 | 2017 | 15 | |
| 15 | 2017 | 21 | |
| 16 | Use of suprathreshold test data to predict the results of quantitative testing in the nasal periphery. | 1990 | 2 |
| 17 | Efficacy and safety of once-daily levobunolol for glaucoma therapy. | 1989 | 14 |
| 18 | 1988 | 13 |
About Colin Mann
Colin Mann is a scholar working on Virology, Infectious Diseases, Ophthalmology, Radiology, Nuclear Medicine and Imaging and Emergency Medical Services, having authored 18 papers that have together received 443 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (6 papers), HIV Research and Treatment (4 papers), SARS-CoV-2 and COVID-19 Research (4 papers), Glaucoma and retinal disorders (3 papers), Viral Infections and Vectors (3 papers), Hepatitis B Virus Studies (2 papers), COVID-19 Clinical Research Studies (2 papers) and Viral Infections and Outbreaks Research (2 papers). The work is most often cited by research in Infectious Diseases (258 citations), Virology (60 citations), Immunology (117 citations), Radiology, Nuclear Medicine and Imaging (101 citations) and Hepatology (32 citations). Colin Mann has collaborated with scholars based in United States, Canada and China. Frequent co-authors include Galit Alter, Erica Ollmann Saphire, Jiang Zhu, Stephanie Fischinger, Xiaohe Lin, Linling He, Florian Krammer, Fatima Amanat, Anil Menon and Ian A. Wilson. Their work appears in journals such as Science Translational Medicine, mBio, Cell Reports, Science Advances and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.